Diagnosis and Monitoring of MBC
Biopsy
Liquid Biopsy
Bone Scan
Magnetic Resonance Imaging (MRI) Scan
Computerized Tomography (CT) Scan
Positron Emission Tomography (PET Scan)
FES Positron Emission Tomography (FES PET Scan)
* NCCN Guidelines® for clinicians and patients have changed to include recommendations for the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent or metastatic breast cancer (MBC).
Sources/Additional Information
- National Cancer Institute Dictionary NCI dictionaries
- National Comprehensive Cancer Network (NCCN). “Metastatic Breast Cancer Guidelines.” NCCN Guidelines for Patients
Find the support you need
Support line
Connect with someone who understands metastatic breast cancer and find the support you need without delay.
Patient Navigation
Talk with our certified patient navigators to get access to the quality healthcare and treatment you need for metastatic breast cancer.
Support Groups
Participate in our support groups to gain insights, share your story, and receive encouragement from those who truly understand metastatic breast cancer.
Clinical Trials
Know your options for treatments in development.
Live Webinars
Gain insights and expert advice from our live webinars designed to empower and inform you every step of the way.
Caregivers
Navigate your way as a cancer caregiver.
Video Library
Access a range of videos featuring specialists and insights into the latest advancements in metastatic breast cancer care.
OUR MBC LIFE
Where can I get more information about metastatic breast cancer?
Call SHARE’s Metastatic Breast Cancer Helpline. Our breast cancer helpline has trained metastatic peers ranging in age from early thirties to eighty. Some have been living with metastatic disease for many years. We can answer your questions, help you figure out your options, and give you realistic hope and support. Call us at 844-ASK-SHARE (844-275-7427).
Our bi-monthly e-newsletter provides information for women living with metastatic breast cancer.